DE2130408A1 - Pharmazeutische Zusammensetzungen - Google Patents

Pharmazeutische Zusammensetzungen

Info

Publication number
DE2130408A1
DE2130408A1 DE19712130408 DE2130408A DE2130408A1 DE 2130408 A1 DE2130408 A1 DE 2130408A1 DE 19712130408 DE19712130408 DE 19712130408 DE 2130408 A DE2130408 A DE 2130408A DE 2130408 A1 DE2130408 A1 DE 2130408A1
Authority
DE
Germany
Prior art keywords
carboxylic acid
hydroxy
formula
ethyl ester
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712130408
Other languages
German (de)
English (en)
Inventor
Gilman David John
O'mant Derrick Michael
Evans David Patrick
Thomson David Summers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2130408A1 publication Critical patent/DE2130408A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712130408 1970-06-19 1971-06-18 Pharmazeutische Zusammensetzungen Pending DE2130408A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2990570 1970-06-19

Publications (1)

Publication Number Publication Date
DE2130408A1 true DE2130408A1 (de) 1971-12-23

Family

ID=10299112

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712130408 Pending DE2130408A1 (de) 1970-06-19 1971-06-18 Pharmazeutische Zusammensetzungen

Country Status (3)

Country Link
DE (1) DE2130408A1 (enExample)
FR (1) FR2100798B1 (enExample)
GB (1) GB1334705A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865831A (en) * 1972-06-09 1975-02-11 Upjohn Co 1,1{40 ,4,4{40 -tetrahydro-4,4{40 -dioxo(6,6{40 biquinoline)-2,2{40 -dicarboxylates
WO2003010146A1 (fr) * 2001-07-20 2003-02-06 Neuro3D Composes derives de quinoleine et quinoxaline, preparation et utilisations

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281131A (en) 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4128649A (en) 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
DE3276432D1 (en) * 1981-03-24 1987-07-02 Ciba Geigy Ag Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
DE3773240D1 (de) * 1986-03-28 1991-10-31 Otsuka Pharma Co Ltd Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
US5270309A (en) * 1987-08-12 1993-12-14 Merck Sharp & Dohme Limited Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
KR20050085580A (ko) 2002-12-11 2005-08-29 쉐링 악티엔게젤샤프트 혈소판 아데노신 디포스페이트 수용체 길항제로서의2-아미노카르보닐-퀴놀린 화합물
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
HUP0900281A2 (hu) * 2009-05-05 2011-01-28 Univ Szegedi Kinurénsav-származékok, eljárás a vegyületek elõállítására, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk fejfájás kezelésére

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1207771A (en) * 1968-03-18 1970-10-07 Warner Lambert Pharmaceutical Anti-virally active quinoline derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865831A (en) * 1972-06-09 1975-02-11 Upjohn Co 1,1{40 ,4,4{40 -tetrahydro-4,4{40 -dioxo(6,6{40 biquinoline)-2,2{40 -dicarboxylates
WO2003010146A1 (fr) * 2001-07-20 2003-02-06 Neuro3D Composes derives de quinoleine et quinoxaline, preparation et utilisations

Also Published As

Publication number Publication date
FR2100798B1 (enExample) 1975-10-10
GB1334705A (en) 1973-10-24
FR2100798A1 (enExample) 1972-03-24

Similar Documents

Publication Publication Date Title
DE60308040T2 (de) Herstellung von 1H-Imidazo-4,5-C]-Chinolin-4-Aminen Ber 1H-Imidazo-4,5-C]-Chinolin-4-Phthalimid-Zwischenprodukten
EP0287907B1 (de) Pyrazolo[3,4-d]pyrimidine, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel
DE60312701T2 (de) Darstellung von 1h-imidazoä4,5-cüchinolin-4-aminen über neue 1h-imidazoä4,5-cüchinolin-4-cyano- und 1h-imidazoä4,5-cüchinolin-4-carboxamid intermediate
DE2614406C2 (enExample)
DE2130408A1 (de) Pharmazeutische Zusammensetzungen
EP0299470B1 (de) Imidazo[1,2-a]pyridine
DE2606265A1 (de) Camptothecin-derivate
DE2149692A1 (de) Pyridochinolinderivate und Verfahren zu deren Herstellung
CH656127A5 (de) Substituierte pyrazolochinoline, verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen.
DE2356903A1 (de) Verfahren zur herstellung substituierter chromon-3-carbonitrile, -carboxamide und -carbonsaeuren
DE2624352C3 (de) Dibenzo [bfl thiepine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende entzündungshemmende Zubereitungen
EP0064255A1 (de) Benzopyranylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel und Zwischenprodukte
DE1470139C3 (de) 5,11-Dihydrodibenz eckige Klammer auf b,e eckige Klammer zu-1,4-oxazepine und Verfahren zu ihrer Herstellung
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE2728643A1 (de) Benzazocine, verfahren zu ihrer herstellung und arzneipraeparate
DE1445153A1 (de) Verfahren zur Herstellung von Benzazocinderivaten
CH621122A5 (enExample)
DE60006026T2 (de) Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte
AT299202B (de) Verfahren zur Herstellung von neuen substituierten Isochinolinen und von deren Säureadditionssalzen
DE2521519A1 (de) Substituierte 9,10-dihydroanthracen- 9,10-imine und heterocyclische (aza) analoge davon und verfahren zur herstellung dieser verbindungen
DE60023063T2 (de) Verfahren zur Herstellung von 2-Phenyl-3-aminopyridinen, deren substituierten Phenylderivaten, und deren Salzen
DE3243820C2 (de) N-Isopropylnoratropin-N-oxid, Verfahren für seine Herstellung und pharmazeutische Zubereitungen, die es enthalten
DE2614836A1 (de) Neue chromonverbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzubereitungen
DE1620523C3 (enExample)
EP0254179A2 (de) Neue Tetrahydrobenzothiazolo-chinoline ihre Herstellung und Verwendung